Introduction {#hiv12410-sec-0005}
============

Improvements in antiretroviral therapy (ART) and obstetric care have contributed to the lowest ever rate of mother‐to‐child transmission of HIV (MTCT) of 0.5% in the UK and Ireland in recent years [1](#hiv12410-bib-0001){ref-type="ref"}. However, MTCT rates are higher in some groups of women, such as those starting ART late in pregnancy [1](#hiv12410-bib-0001){ref-type="ref"}. There are currently around 1200−1300 pregnancies to diagnosed HIV‐positive women in the UK annually [2](#hiv12410-bib-0002){ref-type="ref"}; optimizing their care is important not only to prevent transmission of HIV to their children, but also to ensure good maternal health, and the best possible pregnancy outcome.

The antenatal 'booking' appointment is generally the first contact pregnant women have with maternity services, and provides an opportunity for the identification of maternal and familial risk factors, the offer of timely antenatal screening, and an opportunity to communicate important information to women [3](#hiv12410-bib-0003){ref-type="ref"}. Early booking is particularly important for women living with HIV, whether diagnosed before or during the pregnancy, to ensure that they receive the HIV‐specific care they require in a timely manner, including assessment of clinical and virological status, and initiation of ART for those not already on treatment.

Current international and UK guidelines recommend earlier initiation of antenatal ART than previously [4](#hiv12410-bib-0004){ref-type="ref"}, [5](#hiv12410-bib-0005){ref-type="ref"}. Identifying population groups at increased risk of late antenatal booking and ART initiation will help target efforts towards ensuring equity in access to and uptake of care. Our objective was to investigate the timing of key elements of care of HIV‐positive pregnant women in the UK \[antenatal care booking, HIV laboratory assessment (CD4 count and HIV viral load) and antenatal ART initiation\], to assess whether clinical practice has changed in line with the recommendations, and to investigate factors associated with delayed antenatal booking and initiation of antenatal ART.

Methods {#hiv12410-sec-0006}
=======

Data source {#hiv12410-sec-0007}
-----------

The National Study of HIV in Pregnancy and Childhood (NSHPC) is a well‐established, comprehensive, active surveillance study covering the UK and Ireland. Demographic, clinical and obstetric information is collected using standardized reporting forms [6](#hiv12410-bib-0006){ref-type="ref"}.

Definitions and classifications {#hiv12410-sec-0008}
-------------------------------

Data on UK pregnancies only, resulting in a live or still birth delivered from 1 January 2009 onwards, and reported by the end of June 2014, were utilized. Some degree of reporting delay is to be expected for pregnancies occurring in more recent years. Pregnancies without information on the timing of HIV diagnosis were excluded (*n* = 10). Two calendar periods, 2009--2011 and 2012--2014, were compared to examine changes over time; the earlier period was covered by the 2008 British guidelines recommending antenatal ART initiation by 28 gestational weeks [7](#hiv12410-bib-0007){ref-type="ref"}, and the second by 2012 guidelines recommending ART initiation by 24 weeks [4](#hiv12410-bib-0004){ref-type="ref"}. Both guidelines recommended earlier initiation in women requiring treatment for their own health, and those with high viral loads. We defined late antenatal care booking as booking at ≥ 13 completed gestational weeks, in line with general pregnancy guidelines [3](#hiv12410-bib-0003){ref-type="ref"}, [8](#hiv12410-bib-0008){ref-type="ref"}. Analyses were stratified by the timing of HIV diagnosis: pregnancies in previously diagnosed women (further stratified according to ART status at conception where appropriate) and those in women diagnosed after conception ('newly diagnosed').

Assessment of the timing of the earliest laboratory test was restricted to newly diagnosed women and based on reported date of earliest CD4 count or viral load test (restricted to those taken between 14 days prior to conception and 7 days after delivery). Baseline (pre‐ART) measurements were further restricted to those prior to or up to 7 days after ART initiation (≤ 7 days after delivery in women receiving no antenatal ART). Viral load measurements were grouped reflecting cut‐offs for recommended timing of ART initiation in women not requiring treatment for their own health [4](#hiv12410-bib-0004){ref-type="ref"}. Analyses of timing of antenatal ART initiation were, by definition, restricted to pregnancies not conceived on treatment.

Statistical methods {#hiv12410-sec-0009}
-------------------

Data were analysed using [stata]{.smallcaps} 12.1 (Stata Corp., College Station, TX). Proportions were calculated among those with known information on the variable of interest and compared using the *χ* ^2^ test or *χ* ^2^ test for trend. Medians are presented with interquartile range (IQR) and were compared using the Wilcoxon−Mann−Whitney test.

Logistic regression models were fitted to identify factors associated with late antenatal care booking. Kaplan--Meier analysis was used to describe time to ART initiation graphically, and factors associated with later antenatal ART initiation were analysed using Cox proportional hazards modelling. The proportional hazards assumption was assessed by examining log‐log plots and the model\'s Schoenfeld residuals [9](#hiv12410-bib-0009){ref-type="ref"}. The Therneau−Grambsch test was significant both globally and locally for time period, CD4 count and viral load in both strata; this is not surprising given the relatively large sample sizes. There was evidence of nonparallelism and crossings in the log‐log plots; however, these were mainly in the lower and upper tails of the distribution of time to ART initiation (and thus related to relatively small numbers of women), while the central part of this distribution showed little evidence of departures from the assumption. Variables with overall significance at the *P* \< 0.1 level in univariable analyses were included in multivariable models, with other variables only included if they improved the fit (assessed using the Wald test). Time period was included *a priori*. Some women with a prior diagnosis contributed more than one pregnancy to these analyses, and this clustering was accounted for by using robust standard errors [10](#hiv12410-bib-0010){ref-type="ref"}.

Ethical approval {#hiv12410-sec-0010}
----------------

The National Study of HIV in Pregnancy and Childhood has London Multi‐Centre Research Ethics Committee approval (MREC/04/2/009).

Results {#hiv12410-sec-0011}
=======

Study population {#hiv12410-sec-0012}
----------------

By the end of June 2014, 5693 eligible pregnancies had been reported (5641 live and 52 still births) in 4962 women (3506 deliveries in 2009--2011 and 2187 in 2012--2014). Overall, 2886 (50.7%) pregnancies were among women conceiving on ART, 1601 (28.1%) among diagnosed women not on ART at conception and 1166 (20.5%) among women newly diagnosed during the current pregnancy; the remaining 40 pregnancies were to women diagnosed before conception, but missing information on ART status at conception (Table [1](#hiv12410-tbl-0001){ref-type="table-wrap"}). The proportion of pregnancies in women with previously diagnosed HIV increased from 76.6% in 2009--2011 to 84.2% in 2012--2014 (*P* \< 0.001). Overall, most pregnancies were in women from sub‐Saharan Africa (75.3%), over two‐fifths were reported in London, nearly three‐quarters were in parous women, and half were conceived on ART.

###### 

Pregnancy characteristics stratified by timing of HIV diagnosis

  Characteristic                                               Diagnosed prior to current pregnancy ‐ not on ART at conception   Diagnosed prior to current pregnancy ‐ on ART at conception   Diagnosed prior to current pregnancy (irrespective of ART status)[a](#hiv12410-note-0003){ref-type="fn"}   Newly diagnosed during current pregnancy   Total (all pregnancies)
  ------------------------------------------------------------ ----------------------------------------------------------------- ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------- ------------------------------------------ -------------------------
  Total                                                        1601                                                              2886                                                          4527                                                                                                       1166                                       5693 (100)
  Time period                                                                                                                                                                                                                                                                                                                                        
  2009--2011                                                   1049 (65.5)                                                       1611 (55.8)                                                   2686 (59.3)                                                                                                820 (70.3)                                 3506 (61.6)
  2012--2014                                                   552 (34.5)                                                        1275 (44.2)                                                   1841 (40.7)                                                                                                346 (29.7)                                 2187 (38.4)
  Maternal age at delivery                                                                                                                                                                                                                                                                                                                           
  \< 25 years                                                  209 (13.1)                                                        140 (4.9)                                                     355 (7.8)                                                                                                  177 (15.2)                                 532 (9.3)
  25--34 years                                                 967 (60.4)                                                        1479 (51.2)                                                   2472 (54.6)                                                                                                727 (62.3)                                 3199 (56.2)
  ≥ 35 years                                                   425 (26.5)                                                        1267 (43.9)                                                   1700 (37.6)                                                                                                262 (22.5)                                 1962 (34.5)
  Maternal region of origin                                                                                                                                                                                                                                                                                                                          
  UK/Ireland                                                   276 (17.4)                                                        331 (11.6)                                                    612 (13.7)                                                                                                 157 (13.7)                                 769 (13.7)
  Europe                                                       80 (5.0)                                                          107 (3.8)                                                     190 (4.2)                                                                                                  77 (6.7)                                   267 (4.8)
  Eastern Africa                                               642 (40.5)                                                        1386 (48.7)                                                   2048 (45.8)                                                                                                397 (34.7)                                 2445 (43.5)
  Middle Africa                                                100 (6.3)                                                         190 (6.7)                                                     293 (6.6)                                                                                                  49 (4.3)                                   342 (6.1)
  Western Africa                                               311 (19.6)                                                        498 (17.5)                                                    813 (18.2)                                                                                                 301 (26.3)                                 1114 (19.8)
  Southern Africa                                              77 (4.9)                                                          130 (4.6)                                                     209 (4.7)                                                                                                  61 (5.3)                                   270 (4.8)
  Africa (unspecified)                                         11 (0.7)                                                          30 (1.1)                                                      41 (0.9)                                                                                                   18 (1.6)                                   59 (1.1)
  Elsewhere                                                    88 (5.6)                                                          174 (6.1)                                                     265 (5.9)                                                                                                  85 (7.4)                                   350 (6.2)
  Reporting region                                                                                                                                                                                                                                                                                                                                   
  London                                                       641 (40.2)                                                        1279 (44.4)                                                   1926 (42.6)                                                                                                488 (42)                                   2414 (42.5)
  Midlands and the East                                        409 (25.6)                                                        649 (22.5)                                                    1073 (23.8)                                                                                                284 (24.4)                                 1357 (23.9)
  North                                                        253 (15.9)                                                        414 (14.4)                                                    677 (15)                                                                                                   153 (13.2)                                 830 (14.6)
  South                                                        189 (11.8)                                                        394 (13.7)                                                    591 (13.1)                                                                                                 150 (12.9)                                 741 (13.1)
  Wales, Scotland and Northern Ireland                         103 (6.5)                                                         145 (5)                                                       249 (5.5)                                                                                                  87 (7.5)                                   336 (5.9)
  Parity                                                                                                                                                                                                                                                                                                                                             
  Nulliparous                                                  300 (19.6)                                                        559 (20.4)                                                    864 (20.1)                                                                                                 555 (50.7)                                 1419 (26.3)
  One previous birth                                           592 (38.7)                                                        1018 (37.2)                                                   1626 (37.9)                                                                                                323 (29.5)                                 1949 (36.2)
  Two previous births                                          400 (26.1)                                                        740 (27.0)                                                    1145 (26.7)                                                                                                145 (13.2)                                 1290 (23.9)
  At least three previous births                               238 (15.6)                                                        419 (15.3)                                                    660 (15.4)                                                                                                 72 (6.6)                                   732 (13.6)
  Earliest CD4 count[b](#hiv12410-note-0004){ref-type="fn"}                                                                                                                                                                                                                                                                                          
  ≥ 500 cells/μL                                               484 (33.1)                                                        1163 (44.2)                                                   1654 (40.3)                                                                                                306 (27.9)                                 1960 (37.7)
  350--499 cells/μL                                            432 (29.5)                                                        800 (30.4)                                                    1238 (30.2)                                                                                                258 (23.6)                                 1496 (28.8)
  200--349 cells/μL                                            368 (25.2)                                                        517 (19.7)                                                    886 (21.6)                                                                                                 317 (28.9)                                 1203 (23.1)
  \< 200 cells/μL                                              178 (12.2)                                                        149 (5.7)                                                     327 (8.0)                                                                                                  214 (19.5)                                 541 (10.4)
  Earliest viral load[b](#hiv12410-note-0004){ref-type="fn"}                                                                                                                                                                                                                                                                                         
  \< 50 copies/mL                                              275 (18.1)                                                        2350 (85.9)                                                   2641 (61.8)                                                                                                145 (12.8)                                 2770 (51.4)
  50--29 999 copies/mL                                         931 (61.4)                                                        342 (12.5)                                                    1279 (29.9)                                                                                                700 (61.6)                                 1973 (36.6)
  30 000--99 999 copies/mL                                     213 (14.0)                                                        25 (0.9)                                                      238 (5.6)                                                                                                  168 (14.8)                                 406 (7.5)
  ≥ 100 000 copies/mL                                          98 (6.5)                                                          18 (0.7)                                                      116 (2.7)                                                                                                  124 (10.9)                                 240 (4.5)

ART, antiretroviral therapy.

Values are *n* (%).

Group combines the first two groups presented in the table (*n* = 1601 + 2886) plus 40 pregnancies with missing information on ART status at conception.

Earliest antenatal measurement in that pregnancy, *not* restricted to measurements taken prior to ART initiation.

John Wiley & Sons, Ltd

Timing of booking for antenatal care {#hiv12410-sec-0013}
------------------------------------

Booking date was reported for 5162 (90.7%) pregnancies. It was less well reported for pregnancies from London compared with the rest of England (*P* \< 0.001), and better reported for pregnancies in parous women (*P* \< 0.001). Gestational age at booking had a right‐skewed distribution, with a median (IQR) of 12.1 (10.0--15.6) weeks. Overall, 42.2% of pregnancies were booked late at ≥ 13 completed weeks: 25.7% at 13--17 weeks, 10.0% at 18--23 weeks, and 6.6% at ≥ 24 weeks. The proportion of pregnancies booked late declined from 44.8% in 2009--2011 to 38.2% in 2012--2014 (*P* \< 0.001), although only in previously diagnosed women. Pregnancies in previously diagnosed women were booked earlier than those in newly diagnosed women at a median of 12.0 (9.7--14.9) weeks compared with 13.1 (10.6--18.0) weeks (*P* \< 0.001), respectively (Fig. [1](#hiv12410-fig-0001){ref-type="fig"}a,b); 39.7% of pregnancies in previously diagnosed women were booked late at ≥ 13 weeks (including 14.2% at ≥ 18 weeks), compared with 51.9% (25.7% at ≥ 18 weeks) in newly diagnosed women (both *P* \< 0.001). In previously diagnosed women, there was no association between gestational age at booking and CD4 count (*P* = 0.33).

![Gestation at antenatal care booking for (a) women diagnosed with HIV prior to that pregnancy and (b) women newly diagnosed with HIV during that pregnancy.](HIV-18-161-g001){#hiv12410-fig-0001}

In univariable analyses, maternal region of origin, UK geographical area of report, and parity were significantly associated with late booking in pregnancies to both previously and newly diagnosed women (Table [2](#hiv12410-tbl-0002){ref-type="table-wrap"}). Additionally, in pregnancies to previously diagnosed women, earlier time period, low antenatal CD4 count and not conceiving on ART were associated with increased odds of late booking.

###### 

Univariable and multivariable analyses of factors associated with booking late for antenatal care (≥ 13 gestational weeks), stratified by timing of HIV diagnosis

                                                               Diagnosed prior to current pregnancy   Newly diagnosed during current pregnancy                                                                                                                 
  ------------------------------------------------------------ -------------------------------------- ------------------------------------------ ---------- ------------------- ---------- ---------------- ------------------- ---------- ------------------- ----------
  Time period of delivery                                                                                                                                                                                                                                      
  2009--2011                                                   1027/2415 (42.5)                       1                                                                                    390/748 (52.1)   1                              1                   
  2012--2014                                                   600/1681 (35.7)                        0.75 (0.66--0.85)                          \< 0.001   0.74 (0.64--0.86)   \< 0.001   163/318 (51.3)   0.97 (0.74--1.26)   0.792      1.00 (0.74--1.34)   0.978
  Maternal age at delivery                                                                                                                                                                                                                                     
  \< 25 years                                                  126/318 (39.6)                         1                                                                                    84/162 (51.9)    1                                                  
  25--34 years                                                 855/2232 (38.3)                        0.95 (0.74--1.21)                          0.654      --                             343/666 (51.5)   0.99 (0.70--1.39)   0.936      --                  
  ≥ 35 years                                                   646/1546 (41.8)                        1.09 (0.85--1.40)                          0.481      --                  --         126/238 (52.9)   1.04 (0.70--1.56)   0.830      --                  --
  Maternal region of origin                                                                                                                                                                                                                                    
  UK/Ireland                                                   177/551 (32.1)                         1                                                     1                              48/140 (34.3)    1                              1                   
  Europe                                                       64/173 (37.0)                          1.24 (0.86--1.79)                          0.249      1.51 (1.01--2.26)   0.044      31/70 (44.3)     1.52 (0.85--2.74)   0.160      1.54 (0.81--2.95)   0.188
  Eastern Africa                                               758/1823 (41.6)                        1.50 (1.22--1.85)                          \< 0.001   1.61 (1.28--2.02)   \< 0.001   197/351 (56.1)   2.45 (1.63--3.69)   \< 0.001   2.73 (1.74--4.29)   \< 0.001
  Middle Africa                                                130/264 (49.2)                         2.05 (1.50--2.81)                          \< 0.001   2.24 (1.59--3.14)   \< 0.001   33/48 (68.8)     4.22 (2.09--8.52)   \< 0.001   3.84 (1.82--8.13)   \< 0.001
  Western Africa                                               304/763 (39.8)                         1.40 (1.10--1.77)                          0.006      1.65 (1.27--2.14)   \< 0.001   159/284 (56)     2.44 (1.60--3.71)   \< 0.001   2.14 (1.33--3.43)   0.002
  Southern Africa                                              81/190 (42.6)                          1.57 (1.11--2.23)                          0.012      1.65 (1.13--2.43)   0.010      39/58 (67.2)     3.93 (2.05--7.54)   \< 0.001   3.92 (1.90--8.05)   \< 0.001
  Africa (region unspecified)                                  14/37 (37.8)                           1.29 (0.63--2.64)                          0.492      1.46 (0.68--3.16)   0.335      7/18 (38.9)      1.22 (0.44--3.35)   0.700      1.52 (0.49--4.73)   0.467
  Elsewhere                                                    84/248 (33.9)                          1.08 (0.78--1.51)                          0.639      1.26 (0.88--1.81)   0.207      30/78 (38.5)     1.20 (0.67--2.13)   0.538      1.25 (0.67--2.33)   0.490
  Reporting region                                                                                                                                                                                                                                             
  London                                                       656/1852 (35.4)                        1                                                     1                              265/459 (57.7)   1                              1                   
  Midlands and the East                                        353/836 (42.2)                         1.33 (1.13--1.58)                          0.001      1.42 (1.17--1.71)   \< 0.001   118/240 (49.2)   0.71 (0.52--0.97)   0.031      0.65 (0.45--0.93)   0.021
  North                                                        285/651 (43.8)                         1.42 (1.18--1.71)                          \< 0.001   1.36 (1.10--1.67)   0.004      58/148 (39.2)    0.47 (0.32--0.69)   \< 0.001   0.39 (0.25--0.59)   \< 0.001
  South                                                        212/512 (41.4)                         1.29 (1.05--1.58)                          0.015      1.53 (1.22--1.93)   \< 0.001   64/133 (48.1)    0.68 (0.46--1.00)   0.050      0.66 (0.42--1.03)   0.069
  Wales, Scotland and Northern Ireland                         119/237 (50.2)                         1.84 (1.40--2.42)                          \< 0.001   2.06 (1.50--2.84)   \< 0.001   46/83 (55.4)     0.91 (0.57--1.46)   0.695      1.18 (0.69--2.01)   0.545
  Parity                                                                                                                                                                                                                                                       
  Nulliparous                                                  254/799 (31.8)                         1                                                     1                              265/525 (50.5)   1                              1                   
  One previous birth                                           541/1459 (37.1)                        1.26 (1.05--1.52)                          0.012      1.19 (0.97--1.45)   0.091      150/293 (51.2)   1.03 (0.77--1.37)   0.844      1.05 (0.77--1.44)   0.742
  Two previous births                                          460/1033 (44.5)                        1.72 (1.42--2.09)                          \< 0.001   1.60 (1.30--1.98)   \< 0.001   78/126 (61.9)    1.59 (1.07--2.37)   0.022      1.87 (1.21--2.87)   0.004
  At least three previous births                               297/605 (49.1)                         2.07 (1.66--2.58)                          \< 0.001   1.92 (1.52--2.44)   \< 0.001   36/64 (56.3)     1.26 (0.75--2.13)   0.384      1.29 (0.73--2.29)   0.377
  On ART at conception                                                                                                                                                                                                                                         
  No                                                           650/1458 (44.6)                        1                                                     1                              n/a              --                             n/a                 
  Yes                                                          964/2602 (37.0)                        0.73 (0.64--0.84)                          \< 0.001   0.70 (0.61--0.82)   \< 0.001   n/a              --                  --         n/a                 --
  Earliest CD4 count[c](#hiv12410-note-0008){ref-type="fn"}                                                                                                                                                                                                    
  ≥ 500 cells/μL                                               557/1492 (37.3)                        1                                                     1                              138/278 (49.6)   1                              1                   
  350--499 cells/μL                                            460/1125 (40.9)                        1.16 (0.99--1.36)                          0.067      1.12 (0.95--1.33)   0.183      120/235 (51.1)   1.06 (0.75--1.50)   0.748      (dropped)           --
  200--349 cells/μL                                            330/796 (41.5)                         1.19 (1.00--1.42)                          0.057      1.10 (0.91--1.33)   0.331      153/292 (52.4)   1.12 (0.80--1.55)   0.510      0.93 (0.64--1.36)   0.706
  \< 200 cells/μL                                              152/300 (50.7)                         1.72 (1.34--2.22)                          \< 0.001   1.67 (1.27--2.18)   \< 0.001   105/196 (53.6)   1.17 (0.81--1.69)   0.399      0.95 (0.66--1.36)   0.781
  Earliest viral load[c](#hiv12410-note-0008){ref-type="fn"}                                                                                                                                                                                                   
  \< 30 000 copies/mL                                          1416/3552 (39.9)                       1                                                                                    402/775 (51.9)   1                                                  
  30 000--99 999 cells/μL                                      101/213 (47.4)                         1.36 (1.02--1.81)                          0.034      --                             81/156 (51.9)    1.00 (0.71--1.41)   0.991      --                  
  ≥ 100 000 cells/μL                                           45/106 (42.5)                          1.11 (0.74--1.67)                          0.606      --                  --         57/111 (51.4)    0.98 (0.66--1.46)   0.918      --                  --

aOR, adjusted odds ratio; ART, antiretroviral therapy; CI, confidence interval; OR, odds ratio.

The multivariable model for pregnancies in previously diagnosed women included 3493 observations (and analyses were adjusted for 3149 clusters; i.e. the 3493 pregnancies occurred in 3149 women).

The multivariable model for pregnancies in women diagnosed during their current pregnancy included 938 observations.

Earliest antenatal measurement in that pregnancy, *not* restricted to measurements prior to ART initiation.

John Wiley & Sons, Ltd

Both multivariable models included all variables from the univariable analyses, except maternal age and viral load, which did not improve the fit (Table [2](#hiv12410-tbl-0002){ref-type="table-wrap"}). In multivariable analyses of pregnancies in previously diagnosed women, late booking was associated with earlier time period, originating from abroad (including European‐born women and those from all regions of sub‐Saharan Africa), pregnancy reported from outside London, being parous, not conceiving on ART, and having a low CD4 count. Among pregnancies to newly diagnosed women, late booking was associated with sub‐Saharan African origin (all regions), and higher parity. The odds of late booking were lower for pregnancies reported from elsewhere in England compared with London.

In a sensitivity analysis of the association between being born abroad and late antenatal booking which excluded women known to have arrived in the UK at ≥ 13 gestational weeks (*n* = 86), the results were little changed and the strong association between African origin and late booking, regardless of timing of diagnosis, remained (data not shown).

Timing of first reported laboratory test (CD4 count or viral load) in pregnancies among newly diagnosed women {#hiv12410-sec-0014}
-------------------------------------------------------------------------------------------------------------

The timing of the first reported antenatal HIV‐related laboratory test was available for 1139 of 1166 (97.7%) pregnancies. It was at a median of 17.0 weeks of gestation (IQR 13.4--23.4 weeks), and the interval between conception and testing decreased between the two time periods \[median 17.4 (IQR 13.7--23.6) weeks in 2009--2011 and 16.0 (IQR 12.9--22.6) weeks in 2012--2014; *P* = 0.016\]. Information on both antenatal booking date and date of first antenatal laboratory test was available for 1044 pregnancies (89.5%). The laboratory test was on or after the booking date in 908 of 1044 pregnancies; among these, the median time from booking to laboratory assessment was 2.9 weeks (IQR 1.3--5.9 weeks), with over a third (343 of 908) having a lag of ≥ 4 weeks.

Timing of antenatal ART initiation {#hiv12410-sec-0015}
----------------------------------

In almost all pregnancies, women received antenatal ART (99.2%; 5620 of 5666), and in most this was combination ART (cART) (98.3%; 5507 of 5602; unspecified regimen in 18). Just over half of all pregnancies were conceived on treatment (*n* = 2886), and virtually all women not on ART at conception started ART during pregnancy (98.3%; 2704 of 2750); start date was available for 2619 (1543 with prior diagnosis). Median gestation at ART initiation among all those initiating ART in pregnancy was 21.4 (IQR 18.1--24.5) weeks \[21.0 (IQR 17.6--24.1) weeks in previously diagnosed women, compared with 21.9 (IQR 18.7--25.0) weeks for newly diagnosed women; *P* \< 0.001\] (Fig. [2](#hiv12410-fig-0002){ref-type="fig"}). ART was started significantly earlier in pregnancies delivered in 2012--2014 \[median 20.3 (IQR 16.9--23.4) weeks\] compared with 2009--2011 \[median 22.0 (IQR 18.9--24.7) weeks; *P* \< 0.001\], a trend apparent for both previously and newly diagnosed women (both *P* \< 0.001).

![Cumulative probability of initiating antenatal antiretroviral therapy (ART) by gestational week, stratified by timing of HIV diagnosis.](HIV-18-161-g002){#hiv12410-fig-0002}

Among women not on ART at conception, the median time from antenatal booking to ART initiation was 7.1 (IQR 2.9--11.1) weeks; 7.3 (IQR 2.6--11.6) weeks in those previously diagnosed and 6.9 (IQR 3.0--10.9) weeks in those newly diagnosed. Among pregnancies to newly diagnosed women, the median gap from laboratory testing to ART initiation was 3.0 (IQR 0.3--6.6) weeks. The time from laboratory testing to ART initiation was shorter for pregnancies delivered in 2012--2014 than for those delivered in 2009--2011 \[median 2.7 (IQR 0.1--6.0) *vs*. 3.0 (IQR 0.4--7.0) weeks, respectively; *P* = 0.03\]; it was also shorter for those with a pre‐ART antenatal CD4 count of \< 350 *vs*. ≥ 350 cells/μL \[median 2.7 (IQR 1.1--5.0) *vs*. 5.1 (IQR 2.0--9.1) weeks, respectively; *P* \< 0.001\], and those with viral loads ≥ 30 000 HIV‐1 RNA copies/mL \[median 2.3 (IQR 0.9--4.7) weeks\] compared with \< 30 000 copies/mL \[median 4.3 (IQR 1.7--8.1) weeks\] (*P* \< 0.001).

In univariable analyses of factors associated with the timing of antenatal ART initiation (Table [3](#hiv12410-tbl-0003){ref-type="table-wrap"}), ART was started significantly earlier for pregnancies delivered in the later period compared with 2009--2011, regardless of the timing of HIV diagnosis. Factors associated with shorter time to ART initiation among previously diagnosed women were being reported outside London, having a lower CD4 count and having a higher viral load. There was a similar pattern for newly diagnosed women, but additionally, there were differences according to maternal age and world region of origin, with older women starting ART earlier, and women from Western Africa, in particular, starting later than UK/Irish‐born women.

###### 

Univariable and multivariable Cox proportional hazards analyses of factors associated with shorter time to antenatal antiretroviral therapy (ART) initiation, stratified by timing of HIV diagnosis

  Characteristic                                                                                        Diagnosed prior to current pregnancy   Newly diagnosed during current pregnancy                                                                                                      
  ----------------------------------------------------------------------------------------------------- -------------------------------------- ------------------------------------------ ---------- ------------------- ---------- ----- ------------------- ---------- ------------------- ----------
  Time period                                                                                                                                                                                                                                                                                
  2009--2011                                                                                            1022                                   1                                                     1                              796   1                              1                   
  2012--2014                                                                                            521                                    1.24 (1.10--1.39)                          \< 0.001   1.28 (1.12--1.46)   \< 0.001   326   1.20 (1.05--1.37)   0.006      1.34 (1.15--1.55)   \< 0.001
  Maternal age at delivery                                                                                                                                                                                                                                                                   
  \< 25 years                                                                                           203                                    1                                                                                    173   1                              1                   
  25--34 years                                                                                          932                                    0.98 (0.83--1.16)                          0.800      --                             701   1.12 (0.95--1.33)   0.185      1.15 (0.95--1.40)   0.159
  ≥ 35 years                                                                                            408                                    0.97 (0.81--1.16)                          0.734      --                  --         248   1.31 (1.08--1.60)   0.007      1.17 (0.93--1.47)   0.192
  Maternal region of origin                                                                                                                                                                                                                                                                  
  UK/Ireland                                                                                            270                                    1                                                     --                             154   1                              1                   
  Europe                                                                                                78                                     1.09 (0.85--1.41)                          0.483      --                  --         71    0.87 (0.66--1.16)   0.357      0.75 (0.55--1.02)   0.068
  Eastern Africa                                                                                        616                                    1.05 (0.90--1.23)                          0.520      --                  --         385   0.93 (0.77--1.13)   0.473      0.75 (0.60--0.93)   0.010
  Middle Africa                                                                                         96                                     0.96 (0.73--1.26)                          0.784      --                  --         45    0.91 (0.65--1.27)   0.591      0.82 (0.56--1.20)   0.309
  Western Africa                                                                                        303                                    0.93 (0.78--1.11)                          0.436      --                  --         294   0.73 (0.60--0.89)   0.002      0.60 (0.48--0.76)   \< 0.001
  Southern Africa                                                                                       74                                     1.08 (0.86--1.35)                          0.499      --                  --         58    0.77 (0.56--1.04)   0.090      0.68 (0.47--0.97)   0.032
  Africa (region unspecified)                                                                           10                                     1.01 (0.68--1.51)                          0.951      --                  --         15    0.98 (0.58--1.67)   0.939      0.50 (0.25--1.00)   0.049
  Elsewhere                                                                                             83                                     1.02 (0.80--1.31)                          0.881      --                  --         81    1.17 (0.89--1.54)   0.249      0.92 (0.68--1.25)   0.612
  Reporting region                                                                                                                                                                                                                                                                           
  London                                                                                                621                                    1                                                     1                              473   1                              1                   
  Midlands and the East                                                                                 394                                    1.17 (1.02--1.33)                          0.021      1.13 (0.96--1.32)   0.131      265   1.16 (1.00--1.35)   0.054      1.12 (0.93--1.35)   0.236
  North                                                                                                 240                                    1.28 (1.10--1.48)                          0.001      1.31 (1.10--1.57)   0.003      153   1.28 (1.07--1.54)   0.008      1.25 (1.01--1.55)   0.039
  South                                                                                                 183                                    1.11 (0.94--1.31)                          0.219      1.00 (0.82--1.22)   0.994      144   1.22 (1.01--1.47)   0.038      1.19 (0.94--1.50)   0.140
  Wales, Scotland and Northern Ireland                                                                  99                                     1.21 (0.98--1.50)                          0.079      1.32 (1.02--1.71)   0.035      84    1.24 (0.98--1.57)   0.068      1.20 (0.93--1.55)   0.165
  Parity                                                                                                                                                                                                                                                                                     
  Nulliparous                                                                                           289                                    1                                                     1                              538   1                              --                  
  One previous birth                                                                                    569                                    0.89 (0.77--1.03)                          0.120      0.98 (0.82--1.16)   0.782      312   1.00 (0.87--1.15)   0.971      --                  --
  Two previous births                                                                                   389                                    0.90 (0.77--1.05)                          0.192      0.94 (0.79--1.13)   0.525      141   1.04 (0.86--1.25)   0.682      --                  --
  At least three previous births                                                                        226                                    0.72 (0.59--0.87)                          0.001      0.77 (0.63--0.95)   0.013      68    0.98 (0.76--1.26)   0.852      --                  --
  Baseline CD4 count[c](#hiv12410-note-0013){ref-type="fn"}                                                                                                                                                                                                                                  
  ≥ 500 cells/μL                                                                                        388                                    1                                                     1                              253   1                              1                   
  350--499 cells/μL                                                                                     341                                    1.15 (1.01--1.30)                          0.036      1.13 (0.97--1.32)   0.109      225   1.04 (0.87--1.25)   0.647      1.02 (0.84--1.23)   0.871
  200--349 cells/μL                                                                                     288                                    1.38 (1.17--1.63)                          \< 0.001   1.32 (1.12--1.55)   0.001      280   1.24 (1.04--1.47)   0.015      1.31 (1.09--1.58)   0.003
  \< 200 cells/μL                                                                                       144                                    1.30 (1.02--1.65)                          0.032      1.16 (0.93--1.45)   0.199      191   1.54 (1.28--1.86)   \< 0.001   1.53 (1.23--1.91)   \< 0.001
  Baseline viral load[c](#hiv12410-note-0013){ref-type="fn"}, [d](#hiv12410-note-0014){ref-type="fn"}                                                                                                                                                                                        
  \< 30 000 copies/mL                                                                                   899                                    1                                                     1                              679   1                              1                   
  30 000--99 999 copies/mL                                                                              207                                    1.27 (1.09--1.49)                          0.002      1.24 (1.05--1.46)   0.013      159   1.14 (0.96--1.36)   0.130      1.01 (0.83--1.23)   0.904
  ≥ 100 000 copies/mL                                                                                   90                                     1.56 (1.13--2.16)                          0.007      1.43 (1.11--1.85)   0.006      119   1.32 (1.08--1.60)   0.006      1.21 (0.96--1.51)   0.103

aHR, adjusted hazard ratio; CI, confidence interval; HR, hazard ratio.

An HR of \> 1 indicates a shorter time to ART initiation.

The multivariable model for pregnancies in previously diagnosed women included 1074 observations (and analyses were adjusted for 996 clusters; i.e. the 1074 pregnancies occurred in 996 women).

The multivariable model for pregnancies in women diagnosed during their current pregnancy included 903 observations.

First antenatal measurement in that pregnancy, restricted to measurements prior to ART initiation.

Viral load grouping based on cut‐offs used for recommending timing of ART initiation in women not requiring treatment for their own health \[[4](#hiv12410-bib-0004){ref-type="ref"}.\]

John Wiley & Sons, Ltd

In the multivariable model for pregnancies in previously diagnosed women (Table [3](#hiv12410-tbl-0003){ref-type="table-wrap"}), later time period remained associated with earlier ART initiation (*P* \< 0.001). Compared with London, ART was started somewhat earlier in the North of England (*P* = 0.003) and in Wales, Scotland and Northern Ireland (*P* = 0.035), and women with at least three previous births started later than nulliparous women (*P* = 0.013). There was some suggestion that those with lower CD4 counts started earlier than those with counts ≥ 500 cells/μL, but this only reached statistical significance for those with counts of 200--350 cells/μL (*P* = 0.001). Those with viral loads \> 30 000 copies/mL started earlier than those with lower viral loads (*P* \< 0.01). There was no evidence that including maternal age or world region of origin improved the fit of the model. In a sensitivity analysis excluding women known to have arrived in the UK after conception (*n* = 10), the results were little altered.

For pregnancies in newly diagnosed women, the pattern was similar, with ART started earlier in the later period (*P* \< 0.001). Women from Eastern, Western, and Southern Africa started later than those from the UK/Ireland (all *P* \< 0.05), with some evidence that women from Europe did too (*P* = 0.068). ART was started earlier in all regions/areas of the UK compared with London, although this was only significant for the North of England (*P* = 0.039). Lower CD4 counts were associated with earlier ART. When pregnancies to women known to have arrived in the UK after conception were excluded (*n* = 54), similar patterns were observed, although there was less evidence of an association between Eastern or Southern African origin and later ART (*P* = 0.095 and *P* = 0.081, respectively), while women from Western Africa remained more likely to start ART later (*P* = 0.004) (data not shown). Finally, when the model was restricted to women who booked at \< 13 weeks, evidence remained that women born abroad initiated ART later than those born in the UK/Ireland. In particular, women from Western Africa started later \[adjusted hazard ratio (aHR) 0.50; 95% confidence interval (CI) 0.34--0.74; *P* \< 0.001\], as did those from Southern Africa (*P* = 0.05).

Infant HIV status {#hiv12410-sec-0016}
-----------------

HIV status was reported for 3988 infants by the time of this analysis -- 16 were perinatally infected (half of whom were born to women with a prior diagnosis). Three‐quarters of perinatally infected infants (*n* = 12) were born to women who booked late, 11 of whom were not on ART at conception.

Discussion {#hiv12410-sec-0017}
==========

During the study period, the vast majority (99%) of women received antenatal ART, median gestation at antenatal ART initiation declined over time, and women with high viral loads started ART earlier, in line with changes to UK recommendations [4](#hiv12410-bib-0004){ref-type="ref"}. Longer duration of antenatal ART is associated with a lower risk of vertical transmission of HIV, with a rapid decline in maternal viral load during the first few weeks of ART [1](#hiv12410-bib-0001){ref-type="ref"}, [11](#hiv12410-bib-0011){ref-type="ref"}. The crude vertical transmission rate for deliveries during 2009--2014 is consistent with the previously published UK rate of 0.46% for 2010/2011 [1](#hiv12410-bib-0001){ref-type="ref"}. Although there was a trend towards earlier booking for antenatal care (among previously but not newly diagnosed women), over two‐fifths of pregnancies in HIV‐positive women were booked at ≥ 13 weeks (38% for 2012--2014), compared with 28% of pregnancies in England overall during 2012--2013 [12](#hiv12410-bib-0012){ref-type="ref"}. Later booking among HIV‐positive women probably reflects the cultural and sociodemographic characteristics of this population, and these analyses revealed some important demographic variations in the timeliness of antenatal booking and antenatal ART initiation.

Women from sub‐Saharan Africa were more likely to book late, irrespective of the timing of diagnosis; being born outside the UK and/or being of non‐white ethnicity has been reported as a risk factor for later booking in the general UK population [13](#hiv12410-bib-0013){ref-type="ref"}, [14](#hiv12410-bib-0014){ref-type="ref"}, [15](#hiv12410-bib-0015){ref-type="ref"}, [16](#hiv12410-bib-0016){ref-type="ref"}, and also in the NSHPC data [17](#hiv12410-bib-0017){ref-type="ref"}. US data show that women of black ethnicity experience poorer antenatal care usage [18](#hiv12410-bib-0018){ref-type="ref"}, [19](#hiv12410-bib-0019){ref-type="ref"}, as does the French Perinatal Cohort [20](#hiv12410-bib-0020){ref-type="ref"}. This may in part reflect differing cultural beliefs around antenatal care [21](#hiv12410-bib-0021){ref-type="ref"}, as well as possible barriers to accessing care, including lack of knowledge about the health care system and language difficulties [13](#hiv12410-bib-0013){ref-type="ref"}, [22](#hiv12410-bib-0022){ref-type="ref"}. Culturally appropriate promotion of antenatal care services among ethnic minority women in the UK is one approach that may be beneficial [23](#hiv12410-bib-0023){ref-type="ref"}. Newly diagnosed women born abroad also started ART later than those born in the UK/Ireland (there was no such association among those previously diagnosed), and this was particularly apparent among women from Western Africa. This association persisted in several sensitivity analyses, indicating that it was not simply related to women arriving in the UK late in pregnancy, nor just a reflection of late presentation for antenatal care. In previously diagnosed women, late booking was more common outside London, whereas for newly diagnosed women, late booking was more common in London. Reasons are unclear but may reflect the likely greater concentration of newly arrived migrants in London who may have particular difficulties accessing health care.

Current UK standards state that positive HIV results should be received by maternity services within 10 working days of the sample being taken and the result given to women within 10 days of this, and that there should be 'urgent' referral to the HIV specialist team thereafter [24](#hiv12410-bib-0024){ref-type="ref"}. Although a majority of newly diagnosed women had prompt laboratory assessment, over a third had a gap of ≥ 4 weeks between booking and laboratory assessment. Taking date of laboratory assessment as a proxy for first appointment with the HIV specialist team, the finding suggests that this is an area of practice that may need improving. It is, however, encouraging that, on the whole, newly diagnosed women started ART reasonably promptly with respect to current UK guidelines [4](#hiv12410-bib-0004){ref-type="ref"}. Those with lower CD4 counts started ART significantly sooner, and those with lower CD4 counts or high viral loads had shorter gaps from laboratory testing to ART initiation. Looking forwards, there is a move towards recommending earlier ART initiation. UK treatment guidelines are being revised, and are likely to recommend ART initiation regardless of CD4 count in light of the results of the Strategic Timing of AntiRetroviral Therapy (START) trial [25](#hiv12410-bib-0025){ref-type="ref"}; pregnancy guidelines are consequently expected to change. Recently updated US pregnancy guidelines state that ART should be considered as soon as HIV is diagnosed [26](#hiv12410-bib-0026){ref-type="ref"}.

Higher parity was associated with later booking (most notably among previously diagnosed women), a trend also observed in the general UK population [13](#hiv12410-bib-0013){ref-type="ref"}, [15](#hiv12410-bib-0015){ref-type="ref"}, [27](#hiv12410-bib-0027){ref-type="ref"}. Previously diagnosed women with at least three previous births also started ART later. Reasons are likely to be complex. Different solutions may be required for women who start ART late as a consequence of delayed booking for antenatal care, and those who book for care in good time but experience subsequent delays in ART initiation. An audit of women in the NSHPC who received no antenatal ART or a short duration of ART reported that, among those previously diagnosed, declining treatment was the most common reason (11 of 15; 73%)[28](#hiv12410-bib-0028){ref-type="ref"}.

Women with a prior HIV diagnosis, many of whom will have been diagnosed during a previous pregnancy [29](#hiv12410-bib-0029){ref-type="ref"}, [30](#hiv12410-bib-0030){ref-type="ref"}, should be receiving ongoing HIV care, which might be expected to facilitate early ART initiation in subsequent pregnancies. However, we have previously demonstrated that retention in HIV care after delivery may be suboptimal, with two‐fifths of women presenting with a second pregnancy not being on treatment despite an immunological indication [31](#hiv12410-bib-0031){ref-type="ref"}. Women not on ART at conception booked later than those conceiving on treatment, which is of concern as timely booking and prompt referral to HIV services are needed, especially for those with low CD4 counts. Higher levels of loss to follow‐up from HIV care have been reported among people not receiving treatment [32](#hiv12410-bib-0032){ref-type="ref"}, and disengagement from services may have particularly serious consequences for pregnant women. Although antenatal ART was started earlier in previously diagnosed women with lower CD4 counts, in adjusted analyses there was little difference in ART timing between those with the lowest CD4 counts and the healthiest women. This suggests that there may be a group of high‐risk women who are poorly engaged with care and/or suboptimally managed. It should also be borne in mind that, although women with a CD4 count \< 350 cells/μL should be on ART at conception, those who are not may have concerns about initiating ART early in pregnancy because of fears of teratogenicity.

There are some limitations to this analysis. Women cannot book for antenatal care in the UK before they have entered the country. Although the NSHPC collects date of arrival in the UK, this information was completely missing for around one‐third of women born abroad. Even among those with information reported, over half had only year of arrival (not actual date) provided, so it was not appropriate to utilize this variable in the main analyses; instead, the effect of timing of arrival on the findings was assessed in sensitivity analyses. Week of antenatal booking was missing for 9% of women (81% of whom had a prior HIV diagnosis). Although only a small minority of this group did not start ART before delivery (3.3% of those not conceiving on treatment), this was higher than for women who booked at \< 13 weeks (1.1%). Some of those with missing booking date may represent a particularly high‐risk group requiring targeted interventions to help them engage with services. Meanwhile, earliest laboratory test date during current pregnancy is likely to be the date on which the sample was taken, although a minority of NSHPC respondents may report other dates, such as the date on which the result was reported from the laboratory. There may have been unadjusted confounding as a result of some variables (e.g. socioeconomic factors) not being available in the NSHPC, which has to limit data items collected to maximize reporting. Where delays in ART initiation were apparent, it was not possible to assess to what extent these were health system‐ or provider‐related, structural (socioeconomic environment), or related to women\'s individual circumstances, beliefs and choices. Further exploration of this would be helpful, but is beyond the scope of this analysis.

These analyses, based on comprehensive national data, demonstrate significant improvements in the timeliness of antenatal care booking and antenatal ART initiation in the UK in recent years. However, they also reveal some important demographic variations in access to or uptake of care and highlight the fact that some groups of HIV‐positive women continue to face barriers to timely initiation of antenatal care and ART.
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